Recurrent Uterine Corpus Carcinosarcoma (DBCOND0131672)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04906382 Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer treatment 0 terminated NCT03120624 VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer treatment 1 active_not_recruiting